Strategy for randomised clinical trials in rare cancers

Say Beng Tan, Keith B G Dear, Paolo Bruzzi, David Machin

Research output: Contribution to journalArticlepeer-review

Abstract

Proving that a new treatment is more effective than current treatment can be difficult for rare conditions. Data from small randomised trials could, however, be made more robust by taking other related research into account.

Original languageEnglish
Pages (from-to)47-49
Number of pages3
JournalBritish Medical Journal
Volume327
Issue number7405
Publication statusPublished - Jul 5 2003

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Strategy for randomised clinical trials in rare cancers'. Together they form a unique fingerprint.

Cite this